These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 12542064)

  • 41. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
    Marder VJ
    Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombolysis in the treatment of submassive pulmonary embolism.
    Mascitelli L; Pezzetta F
    Arch Intern Med; 2003 May; 163(10):1238; author reply 1238. PubMed ID: 12767964
    [No Abstract]   [Full Text] [Related]  

  • 43. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibrinolytic guidelines in diabetes.
    Sharma GV; Mukerjee DK; Sasahara AA
    Geriatrics; 1982 Apr; 37(4):38-42, 46. PubMed ID: 7060947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of intractable postoperative blepharoplasty bleeding after thrombolysis for a pulmonary embolism.
    Burroughs JR
    Ophthalmic Plast Reconstr Surg; 2009; 25(4):314-5. PubMed ID: 19617794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness and cost effectiveness of thrombolysis in patients with acute pulmonary embolism.
    Zamanian RT; Gould MK
    Curr Opin Pulm Med; 2008 Sep; 14(5):422-6. PubMed ID: 18664972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benefits and risks associated with thrombolysis for pulmonary embolism.
    Bova C
    JAMA; 2014 Oct; 312(15):1589. PubMed ID: 25321915
    [No Abstract]   [Full Text] [Related]  

  • 48. Benefits and risks associated with thrombolysis for pulmonary embolism.
    Bradford MA; Adhikari NK; Friedrich JO
    JAMA; 2014 Oct; 312(15):1588-9. PubMed ID: 25321914
    [No Abstract]   [Full Text] [Related]  

  • 49. Benefits and risks associated with thrombolysis for pulmonary embolism--reply.
    Chatterjee S; Giri J
    JAMA; 2014 Oct; 312(15):1589-90. PubMed ID: 25321916
    [No Abstract]   [Full Text] [Related]  

  • 50. Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis.
    Nakamura S; Takano H; Kubota Y; Asai K; Shimizu W
    J Thromb Haemost; 2014 Jul; 12(7):1086-95. PubMed ID: 24829097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous mechanical thrombectomy in patients with submassive pulmonary embolism: an Underutilized and Understudied Tool!
    Moussa ID
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):148-9. PubMed ID: 21181975
    [No Abstract]   [Full Text] [Related]  

  • 52. Successful thrombolysis of submassive pulmonary embolism by tissue plasminogen activator.
    Al-Khuwaitir TS; Al-Mugheiri AM; Wani BA; Sherbeeni SM
    Saudi Med J; 2003 Jun; 24(6):680-2. PubMed ID: 12847605
    [No Abstract]   [Full Text] [Related]  

  • 53. Thrombolytic treatment of acute pulmonary embolism in myotonic dystrophy.
    Jabr FI
    J Emerg Med; 2006 Feb; 30(2):220-1. PubMed ID: 16567263
    [No Abstract]   [Full Text] [Related]  

  • 54. Bilateral intraorbital haematomata following thrombolysis for pulmonary embolism.
    Gough-Palmer A; Harman F
    Eye (Lond); 2009 Apr; 23(4):987-9. PubMed ID: 18451873
    [No Abstract]   [Full Text] [Related]  

  • 55. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator].
    García-Jiménez A; Iriarte Sotés P; Fernández González CJ; Garrote Freire A; González Tutor J
    An Med Interna; 2003 Mar; 20(3):163-4. PubMed ID: 12756909
    [No Abstract]   [Full Text] [Related]  

  • 57. Hazards of thrombolytic therapy for stroke: the real-world experience.
    Hurley JC
    Intern Med J; 2007 May; 37(5):348-9; author reply 349-50. PubMed ID: 17504292
    [No Abstract]   [Full Text] [Related]  

  • 58. Low-Dose Systemic Alteplase (tPA) for the Treatment of Pulmonary Embolism.
    Brandt K; McGinn K; Quedado J
    Ann Pharmacother; 2015 Jul; 49(7):818-24. PubMed ID: 25857308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pulmonary thromboembolism with massive vaginal bleeding due to thrombolytic therapy.
    Ekim N; Kokturk N; Yegin D; Kokturk O; Habesoglu MA
    Respirology; 2003 Jun; 8(2):246-8. PubMed ID: 12753544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pulmonary embolism: could thrombolysis be extended to patients with intermediate-risk pulmonary embolism?].
    Bouzerda A; Serghini I; Kharass AE
    Pan Afr Med J; 2017; 26():238. PubMed ID: 28690752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.